Varelas S.a. Chemicals And Diagnostics
VARELAS S.A. Chemicals & Diagnostics is a Greece- and Cyprus-based distributor of diagnostics reagents, laboratory instrumentation, life-science research products and laboratory services, supplying hospitals, diagnostic laboratories and research institutions with scientific technical support from its Kifissia headquarters.
- Company typePrivate
- Founded1950
- HeadquartersKifisiá, Greece
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Varelas S.a. Chemicals And Diagnostics does
VARELAS S.A. Chemicals & Diagnostics (ΒΑΡΕΛΑΣ Α.Ε. Χημικά & Διαγνωστικά) is a Greek distributor of diagnostics reagents, life-science research products, laboratory instrumentation and related laboratory services. It serves clinical diagnostics laboratories and hospitals (public and private), diagnostic centres, universities, research institutes and R&D laboratories in Greece and Cyprus. The company was founded in the early 1950s by pharmacist Nikolaos D. Varelas as N.D. VARELAS S.A. Chemicals & Pharmaceuticals, originally distributing and trading medicines, and later repositioned into diagnostics and life-science research supply. It is an unlisted Greek joint-stock company (Α.Ε.) affiliated with the Galenica Group and employs 11-50 people.
The product portfolio is multi-brand and organised by business sector rather than as a single platform, covering haematology (immunohaematology, special blood transfusion tests, haemostasis, plasma cell dyscrasias), immunology and life-science research (autoimmunity, immunodeficiency, histocompatibility/immunogenetics, cytokines and other research molecules, proteins, molecular biology reagents, microarrays, laboratory consumables), microbiology (infectious immunology, bacteriology, virology, mycology, parasitology, tuberculosis), cytology, molecular diagnostics, hormones, and a broad instrumentation catalogue (automated blood culture, automated ID/AST, real-time PCR, CLIA, thermal cyclers, turbidimeters/nephelometers, protein electrophoresis, nucleic acid analysis and extraction, media preparation, immunofluorescence, hybridisation/immunodot, microELISA, sample storage systems). Alongside product sales, the company operates laboratory service lines: oligonucleotide synthesis, sequencing, PCR and thermal cycler validation, molecular testing services, and external quality assessment programmes spanning haematology, immunocytochemistry, immunology, histocompatibility/immunogenetics, clinical chemistry, blood transfusion laboratory practice, microbiology and blood coagulation. The technical substrate is in-house service and logistics infrastructure rather than proprietary technology: an Order Entry and Distribution Centre, an Order Entry/Customer Service Centre at the Kifissia headquarters, a Technical Support Department staffed by specialised scientific personnel, and an in-house Order Entry/Customer Service Centre supported by Galenica Group IT, cloud and hosting affiliates.
Revenue is generated through three streams: transaction revenue from distributing diagnostics reagents, kits and consumables; product-sale revenue from laboratory instrumentation; and professional-services revenue from laboratory/technical services and external quality assessment, supported by pre-, during- and post-sales technical support. Pricing is quote-based and not publicly disclosed - no prices, tiers or discounts are published. Go-to-market is primarily direct: order entry by call centre (info@varelas.gr, +30 210 5281900) and the Kifissia distribution centre, inside and field sales into laboratories, hospitals and research institutions, a representative office serving the Northern Greek market from Thessaloniki, and exclusive distribution partnerships (for example, ABL Diagnostics in Cyprus and Montenegro). Demand generation is supported by co-hosted scientific webinars with product partners (a Binding Site Freelite series on multiple myeloma, nephrology, osteoporosis and neurological disorders), online education, a newsletter service and a bilingual corporate website. No revenue figure is disclosed; the only financial document referenced is a FY2015 statutory financial statements PDF (41st corporate year), and no funding rounds, acquisitions, mergers or listing events are disclosed.
Varelas S.a. Chemicals And Diagnostics firmographics
Firmographics- Name
- Varelas S.a. Chemicals And Diagnostics
- Legal name
- VARELAS S.A. Chemicals & Diagnostics (ΒΑΡΕΛΑΣ Α.Ε. Χημικά & Διαγνωστικά)
- Website
- https://varelas.gr
- Company type
- Private
- Founded year
- 1950
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- VARELAS S.A. Chemicals & Diagnostics is a Greece- and Cyprus-based distributor of diagnostics reagents, laboratory instrumentation, life-science research products and laboratory services, supplying hospitals, diagnostic laboratories and research institutions with scientific technical support from its Kifissia headquarters.
- Ownership category
- akta.pro rank
Varelas S.a. Chemicals And Diagnostics industry classification
Industry- Product category
- Diagnostics Reagents, Laboratory Instrumentation and Life-Science Supply Distribution
- NAICS
- Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Medical Laboratories (8071), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Commercial Physical & Biological Research (8731)
- akta.pro industry
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD)Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory DiagnosticsMolecular & Genetic Testing (PCR/NGS/qPCR)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Testing & Analytical ServicesMolecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Equipment, Instruments & ConsumablesMicrobiology & Infectious Disease Diagnostics (Culture/ID/AST)Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory DiagnosticsQuality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
Keywords
Where Varelas S.a. Chemicals And Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Kifisiá
- HQ country
- Greece
- HQ region
- Europe
Offices2 records
Markets served
Varelas S.a. Chemicals And Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Distribution and sale of diagnostics reagents, kits and consumables: Core revenue comes from supplying and distributing high quality, innovative products (diagnostics reagents, immunohaematology, microbiology, molecular diagnostics, life-science research reagents, laboratory consumables) to the Greek health and life-science research market, generating one-time transaction revenue from order fulfilment through the company's Order Entry and Distribution Centre in Kifissia.
- Instrumentation and equipment sales: Sale and supply of laboratory instrumentation (automated blood culture, automated ID/AST, real-time PCR, CLIA, thermal cyclers, turbidimeters/nephelometers, electrophoresis, hybridisation & immunodot, microELISA, sample storage systems) as a product-sale revenue stream.
- Laboratory and technical services: Service revenue from oligonucleotide synthesis, sequencing services, PCR/thermal cycler validation, molecular testing services and external quality assessment programmes, complemented by pre-, during- and post-sales technical support delivered by the Technical Support Department.
- Pharmaceutical / health product trading (legacy business): Founded in the early 1950s for the distribution and trading of medicines, the company developed rapidly into one of the largest pharmaceutical trading enterprises in Greece; the current entity operates under the Chemicals & Diagnostics name.
Go-to-market motion4 records
Distribution channels3 records
Marketing channels6 records
Varelas S.a. Chemicals And Diagnostics product offering
Product offeringCore offering
VARELAS S.A. is a Greek distributor of diagnostics reagents and kits (haematology, immunohaematology, haemostasis, microbiology, cytology, molecular diagnostics, hormones, life-science research reagents) and laboratory instrumentation, together with related laboratory services including oligonucleotide synthesis, sequencing, PCR/thermal cycler validation, molecular testing and external quality assessment programmes. Products are sourced from third-party manufacturers and supplied to clinical diagnostics laboratories, hospitals and life-science research institutions across Greece and Cyprus through its own Order Entry and Distribution Centre in Kifissia, backed by a scientific technical support department.
Product overview
VARELAS S.A. (ΒΑΡΕΛΑΣ Α.Ε. Χημικά & Διαγνωστικά) is a Greek distributor — not a single unified software product — whose offering is a multi-brand, multi-sector portfolio of diagnostics reagents, life-science research products, laboratory instrumentation and related services, delivered to Greek and Cypriot health and research markets. The portfolio is organised as business-sector product lines rather than a core platform with add-on modules: Haematology (Immunohaematology, Special Blood Transfusion Tests, Haemostasis, Plasma Cell Dyscrasias), Life Science Research (Molecular Biology Reagents, Laboratory Consumables, Cytokines & Other Research Molecules, Microarrays, Oligonucleotide Synthesis Services, Sequencing Services, Sample Storage and Management Systems, PCR Validation), Instrumentation (Nucleic Acid Analysis, Immunodiffusion, Immunofluorescence, Hyperthermia Pump, Gel Documentation, Nucleic Acid Extraction, Automated Blood Culture Systems, Automated ID/AST Systems, Blood Transfusion Lab Instrumentation, Proteins Electrophoresis, Thermal Cyclers, Turbidimeters/Nephelometers, Media Preparation and Dispensing, Haemostasis and Immunohaematology Instrumentation, Vein Detection System, Rapid Infuser, Microarray Platforms, Hybridization & Immunodot, microELISA, Real Time PCR, CLIA), Microbiology (Infectious Immunology, Bacteriology, Virology, Mycology, Parasitology, Tuberculosis), Cytology (Liquid Based Cytology), Molecular Diagnostics (Pathogen Detection, Genetic Abnormalities, Genetic Diseases, Histocompability, Blood Group Typing), Hormones, Molecular Testing Services, Immunology (Autoimmunity, Immunodeficiency Test, Histocompability, Cytokines & Other Research Molecules, Proteins) and External Quality Assessment programmes. These sector lines are complemented by service layers — the Distribution Network and Technical Support functions and an online webinar training series (with Binding Site, featuring the Freelite free light chain kits for multiple myeloma monitoring) — so instrumentation, reagents and consumables are sold together with logistics, training and quality-assessment support rather than as one connected software platform.
Differentiator
Problem solved
Functional benefit
Products and services
- Immunohaematology
- Special Blood Transfusion Tests
- Haemostasis
- Plasma Cell Dyscrasias
- Molecular Biology Reagents
- Laboratory Consumables
- Cytokines & Other Research Molecules
- Proteins
- Microarrays
- Oligonucleotide Synthesis Services
- Sequencing Services
- Sample Storage and Management Systems
- PCR Validation
- Thermal Cycler Validation
- Nucleic Acid Analysis
- Immunodiffusion
- Immunofluorescence
- Hyperthermia Pump
- Gel Documentation
- Nucleic Acid Extraction
- Automated Blood Culture Systems
- Automated ID/AST Systems
- Blood Transfusion Lab Instrumentation
- Proteins Electrophoresis
- Thermal Cyclers
- Turbidimeters / Nephelometers
- Media Preparation and Dispensing
- Haemostasis Instrumentation
- Immunohaematology Instrumentation
- Vein Detection System
- Rapid Infuser
- Microarray Platforms
- Hybridization & Immunodot
- microELISA
- Real Time PCR
- CLIA
- Microbiology
- Infectious Immunology
- Bacteriology
- Virology
- Mycology
- Parasitology
- Tuberculosis
- Cytology
- Liquid Based Cytology
- Molecular Diagnostics
- Pathogen Detection
- Genetic Abnormalities
- Genetic Diseases
- Histocompability Molecular Diagnostics
- Blood Group Typing
- Hormones
- Molecular Testing Services
- Immunology
- Autoimmunity
- Immunodeficiency Test
- Histocompability
- External Quality Assessment
- Distribution Network
- Technical Support
Quantifiable outcome
- Operations spanning more than four decades of continuous development of the Greek health and life-science research market
- +1 more outcomes
Companies that use Varelas S.a. Chemicals And Diagnostics
Customer profileSegments5 records
Ideal customer profiles4 records
Varelas S.a. Chemicals And Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Varelas S.a. Chemicals And Diagnostics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- ABL DiagnosticscorePress release published on 2025-10-21 by einpresswire titled 'ABL Diagnostics Expands Global Footprint with Additional Exclusive Distribution Partnerships in Cyprus and Montenegro', covering new exclusive distribution partnerships in Cyprus and Montenegro. This aligns with VARELAS' own distribution network statement that distribution in Greece and Cyprus is managed from its Kifissia headquarters.
- Binding SitecoreVARELAS S.A. co-hosts and promotes a series of online scientific webinars with Binding Site, presented by Dr. James Last (Head of Medical Scientific Communication at Binding Site). Sessions covered the Freelite kits in multiple myeloma monitoring (24 April 2023), nephrology (26/7/23), serum testing in osteoporosis and bone fractures (25/9/23) and CSF/neurological disorders (27/11/23). The webinars are hosted on VARELAS' 'Διαδικτυακές Εκπαιδύσεις' section with registration links to Binding Site's platform.
- Galenica Group (ΟΜΙΛΟΣ Galenica)coreVARELAS S.A. is affiliated with the Galenica Group: other companies of the Galenica group provide supporting IT, cloud computing and hosting services with access to VARELAS' information systems and electronic databases. The group also includes the Galenica and Techline sites linked from VARELAS' website navigation.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Varelas S.a. Chemicals And Diagnostics competitors and assessment
Company assessmentDirect peers
- Medochemie GmbH: A Munich-based IVD and laboratory product distributor serving clinical laboratories, hospitals and research institutes across Europe with a broad multi-brand catalogue plus technical support. It is the closest business-model analogue to Varelas' reagent-plus-instrument distribution operation.
- Randox: Northern Ireland-based diagnostics group that supplies IVD reagents and instruments and, crucially, runs its own external quality assessment/proficiency testing schemes across laboratory disciplines. It overlaps directly with Varelas' dual model of product distribution plus EQA programmes.
- Menarini Diagnostics: Italian diagnostics group supplying immunoassay, molecular and specialised testing solutions to clinical laboratories and hospitals with a strong Southern European footprint. Comparable in serving the same hospital-lab customer base with haematology, immunology and molecular product lines.
- Biosystems: Barcelona-based IVD manufacturer and distributor focused on microbiology, haematology and clinical chemistry consumables and reagents. It is directly comparable as a Southern European specialist supplier of laboratory diagnostics into the same hospital and reference-lab channel.
Emerging players
- ABL Diagnostics: Portuguese specialist in molecular diagnostics, blood group genotyping and immunogenetics whose portfolio Varelas distributes exclusively in Cyprus and Montenegro. It intersects directly with Varelas' molecular diagnostics and blood-transfusion product lines while remaining a small, niche manufacturer.
Broad incumbents
- bioMérieux: Global diagnostics incumbent in microbiology (automated blood culture and ID/AST), immunochemistry and molecular detection — precisely the categories Varelas distributes as instrumentation and reagents. It sets the vendor terms, pricing benchmarks and competitive bar that Varelas must sell against.
- Roche Diagnostics: World's largest IVD supplier with broad haematology, immunology, molecular and microbiology portfolios sold directly and through distributors in Greece and Cyprus. It is a principal supplier and competitor for the same Greek laboratory budgets.
- Sysmex: Haematology and diagnostics incumbent whose analysers (and associated reagents) are sold into Greek and Cypriot laboratories, frequently via local distribution partners. It is directly relevant to Varelas' haematology, immunohaematology and haemostasis instrumentation and reagent lines.
- Beckman Coulter: Large laboratory instrumentation and IVD supplier (analysers, centrifuges, automated systems and reagents) selling into the same Greek clinical and research laboratories. It is a broad incumbent competing for the same instrumentation placements that anchor Varelas' consumable pull-through.
Others
- Illumina: Sequencing platform and consumables supplier whose technology underpins the sequencing services and molecular workflows Varelas offers to Greek research and clinical customers. It is an ecosystem/supplier relationship rather than a like-for-like distributor competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Varelas S.a. Chemicals And Diagnostics social profiles
Digital presenceVarelas S.a. Chemicals And Diagnostics compliance and trust
Trust signalCompliance4 records
Varelas S.a. Chemicals And Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Varelas S.a. Chemicals And Diagnostics leadership team
Management profileNumber of profiles
Varelas S.a. Chemicals And Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Varelas S.a. Chemicals And Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Varelas S.a. Chemicals And Diagnostics
What does Varelas S.a. Chemicals And Diagnostics do?
VARELAS S.A. is a Greek distributor of diagnostics reagents and kits (haematology, immunohaematology, haemostasis, microbiology, cytology, molecular diagnostics, hormones, life-science research reagents) and laboratory instrumentation, together with related laboratory services including oligonucleotide synthesis, sequencing, PCR/thermal cycler validation, molecular testing and external quality assessment programmes. Products are sourced from third-party manufacturers and supplied to clinical diagnostics laboratories, hospitals and life-science research institutions across Greece and Cyprus through its own Order Entry and Distribution Centre in Kifissia, backed by a scientific technical support department.
Is Varelas S.a. Chemicals And Diagnostics a public or private company?
Varelas S.a. Chemicals And Diagnostics is a private company. It is classified as family owned and is currently operating.
When was Varelas S.a. Chemicals And Diagnostics founded?
Varelas S.a. Chemicals And Diagnostics was founded in 1950. It employs 11 to 50 people.
Where is Varelas S.a. Chemicals And Diagnostics based?
Varelas S.a. Chemicals And Diagnostics is headquartered in Kifisiá, Greece, in the Europe region.
How does Varelas S.a. Chemicals And Diagnostics make money?
Four revenue lines are on record. Distribution and sale of diagnostics reagents, kits and consumables are the primary driver. The others are instrumentation and equipment sales, laboratory and technical services and pharmaceutical / health product trading (legacy business).
Who are Varelas S.a. Chemicals And Diagnostics's main competitors?
Direct peers on record are Medochemie GmbH, Randox, Menarini Diagnostics and Biosystems. ABL Diagnostics is listed as an emerging player. Broad incumbents are bioMérieux, Roche Diagnostics, Sysmex and Beckman Coulter. Illumina is listed as an others.
Does Varelas S.a. Chemicals And Diagnostics have an API?
No public API is recorded for Varelas S.a. Chemicals And Diagnostics.
What industry is Varelas S.a. Chemicals And Diagnostics in?
Varelas S.a. Chemicals And Diagnostics's product category is Diagnostics Reagents, Laboratory Instrumentation and Life-Science Supply Distribution. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 6215 and its SIC code is 5047.